Npyy5 antagonists
US6699891B1 · kind B1 · utility
74Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2002 |
| Grant date | Mar 2, 2004 |
| Priority date | — |
| Expiry date | May 1, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I): wherein R1 is lower alkyl, cycloalkyl or the like,R2 is hydrogen, lower alkyl or the like,n is 1 or 2,X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like,Y is CONR7, CSNR7, NR7CO, NR7CS or the like,Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R7 is hydrogen or lower alkyl,prodrug, pharmaceutically acceptable salt or solvate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.